Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Morin is a naturally occurring polyphenolic flavonol found in various plants such as *Maclura pomifera* (Osage orange), *Maclura tinctoria*, and guava leaves. It exhibits a broad spectrum of biological activities including antioxidant, anti-inflammatory, antidiabetic, antitumoral, antihypertensive, antibacterial, hypouricemic (uric acid-lowering), and neuroprotective effects. Mechanistically, morin acts by modulating the activity of multiple enzymes and pathways; notably it inhibits xanthine oxidase (reducing uric acid synthesis) and urate anion transporter 1 (URAT1/SLC22A12) in the kidney to decrease uric acid reabsorption. Morin also inhibits amyloid formation by islet amyloid polypeptide and has been shown to interact with several signaling pathways relevant to inflammation and cell survival. Preclinical studies indicate low toxicity with chronic administration[2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morin.